Financhill
Buy
53

MEDP Quote, Financials, Valuation and Earnings

Last price:
$549.22
Seasonality move :
3.24%
Day range:
$541.02 - $552.60
52-week range:
$250.05 - $626.26
Dividend yield:
0%
P/E ratio:
38.41x
P/S ratio:
7.05x
P/B ratio:
52.68x
Volume:
216.9K
Avg. volume:
279.6K
1-year change:
56.67%
Market cap:
$15.5B
Revenue:
$2.1B
EPS (TTM):
$14.30

Earnings Data

Next earnings date for MEDP
Feb 09
2026
Most recent earnings per share
$3.86
Beat by $0.29
(Oct 22/2025)
Consensus Estimate
$3.57
(Oct 22/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

MEDP Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/09/2026 Q4 $689.4M -- -- $4.21 --
10/22/2025 Q3 $641M $659.9M $3.86 $3.57 $0.29
07/21/2025 Q2 $538.8M $603.3M $3.10 $3.00 $0.10
04/21/2025 Q1 $526.3M $558.6M $3.67 $3.07 $0.61
02/10/2025 Q4 $535M $536.6M $3.67 $3.12 $0.55
10/21/2024 Q3 $541M $533.3M $3.01 $2.87 $0.14
07/22/2024 Q2 $528.4M $528.1M $2.75 $2.63 $0.13
04/22/2024 Q1 $512M $511M $3.20 $2.49 $0.71
02/12/2024 Q4 $497.8M $498.4M $2.46 $2.52 -$0.06
10/23/2023 Q3 $475.8M $492.5M $2.22 $2.19 $0.03
07/24/2023 Q2 -- $460.9M $1.93 -- --
04/24/2023 Q1 -- $434.1M $2.27 -- --
02/13/2023 Q4 -- $394.1M $2.12 -- --
10/24/2022 Q3 -- $383.7M $2.05 -- --
07/25/2022 Q2 -- $351.2M $1.46 -- --
04/25/2022 Q1 -- $330.9M $1.69 -- --
02/14/2022 Q4 -- $308.6M $1.32 -- --
10/25/2021 Q3 -- $295.6M $1.29 -- --
07/26/2021 Q2 -- $278.3M $1.06 -- --
04/26/2021 Q1 -- $260M $1.14 -- --
02/15/2021 Q4 -- $259.7M $1.35 -- --
10/26/2020 Q3 -- $230.4M $1.09 -- --
07/27/2020 Q2 -- $205M $0.64 -- --
04/28/2020 Q1 -- $230.9M $0.76 -- --
02/24/2020 Q4 -- $229.9M $0.78 -- --
10/28/2019 Q3 -- $216.2M $0.63 -- --
07/29/2019 Q2 -- $214.1M $0.73 -- --
04/29/2019 Q1 -- $200.7M $0.51 -- --
02/25/2019 Q4 -- $192.1M $0.61 -- --
10/29/2018 Q3 -- $179.3M $0.52 -- --
07/31/2018 Q2 -- $170.1M $0.45 -- --
04/30/2018 Q1 -- $163.1M $0.40 -- --
02/26/2018 Q4 -- $112.7M $0.30 -- --
10/30/2017 Q3 -- $110.6M $0.25 -- --
07/31/2017 Q2 -- $106.2M $0.23 -- --
05/02/2017 Q1 -- $106.6M $0.20 -- --
12/31/2016 Q4 -- $108.2M -$0.00 -- --
09/30/2016 Q3 -- $107.8M $0.13 -- --
06/30/2016 Q2 -- $106M $0.12 -- --
03/31/2016 Q1 -- $99.6M $0.08 -- --

Medpace Holdings, Inc. Earnings Questions

  • How Much did Medpace Holdings, Inc. Generate in Revenue Last Quarter?

    Medpace Holdings, Inc. reported $659.9M worth of top line sales in its most recent quarter.

  • Did Medpace Holdings, Inc. Beat Earnings Last Quarter?

    Medpace Holdings, Inc. announced earnings per share of $3.86 which represents a beat of analyst forecast a $3.57 per share.

  • Is Medpace Holdings, Inc. Profitable?

    Medpace Holdings, Inc. reported $189.9M that represents $6.59 per share over the last quarter.

  • What is the Analyst Consensus for Medpace Holdings, Inc. EPS Next Year?

    Medpace Holdings, Inc.'s earnings are forecast to grow from $12.63 per share to $12.29 per share next year representing an increase of 19.72%.

  • When is Medpace Holdings, Inc.'s Earnings Date?

    Medpace Holdings, Inc.'s next earnings date is February 9, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Netflix Buy Warner Bros?
Why Did Netflix Buy Warner Bros?

Following a bidding war, Netflix (NASDAQ:NFLX) has announced its intention…

Why Did SoFi Stock Drop?
Why Did SoFi Stock Drop?

Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…

Will Robinhood Win AI Investing?
Will Robinhood Win AI Investing?

Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…

Stock Ideas

Buy
54
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
59
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
67
GPCR alert for Dec 9

Structure Therapeutics, Inc. [GPCR] is up 102.52% over the past day.

Buy
62
SMX alert for Dec 9

SMX (Security Matters) Plc [SMX] is down 59.64% over the past day.

Buy
90
KYMR alert for Dec 9

Kymera Therapeutics, Inc. [KYMR] is up 41.67% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock